Should Endometriosis-Associated Ovarian Cancer Alter the Management of Women with an Intact Endometrioma in the Reproductive Age?
Abstract
:1. Introduction
2. Lifetime Risk of EAOC
3. Age at Diagnosis of EAOC
4. Clinical Manifestations of EAOC
5. Surgery or Conservative Management for an Intact Endometrioma
6. When Should Surgery Be Considered for an Intact Endometrioma?
7. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Shafrir, A.L.; Farland, L.V.; Shah, D.K.; Harris, H.R.; Kvaskoff, M.; Zondervan, K.; Missmer, S.A. Risk for and consequences of endometriosis: A critical epidemiologic review. Best. Pract. Res. Clin. Obstet. Gynaecol. 2018, 51, 1–15. [Google Scholar] [CrossRef] [PubMed]
- Zafrakas, M.; Grimbizis, G.; Timologou, A.; Tarlatzis, B.C. Endometriosis and ovarian cancer risk: A systematic review of epidemiological studies. Front. Surg. 2014, 1, 14. [Google Scholar] [CrossRef] [PubMed]
- Smolarz, B.; Szyłło, K.; Romanowicz, H. Endometriosis: Epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int. J. Mol. Sci. 2021, 22, 10554. [Google Scholar] [CrossRef] [PubMed]
- Ozkan, S.; Murk, W.; Arici, A. Endometriosis and infertility: Epidemiology and evidence-based treatments. Ann. N.Y Acad. Sci. 2008, 1127, 92–100. [Google Scholar] [CrossRef] [PubMed]
- Jenkins, S.; Olive, D.L.; Haney, A.F. Endometriosis: Pathogenetic implications of the anatomic distribution. Obstet. Gynecol. 1986, 67, 335–338. [Google Scholar] [PubMed]
- Hermens, M.; van Altena, A.M.; Nieboer, T.E.; Schoot, B.C.; van Vliet, H.A.A.M.; Siebers, A.G.; Bekkers, R.L.M. Incidence of endometrioid and clear-cell ovarian cancer in histologically proven endometriosis: The ENOCA population-based cohort study. Am. J. Obstet. Gynecol. 2020, 223, 107.e1–107.e11. [Google Scholar] [CrossRef]
- Kvaskoff, M.; Mahamat-Saleh, Y.; Farland, L.V.; Shigesi, N.; Terry, K.L.; Harris, H.R.; Roman, H.; Becker, C.M.; As-Sanie, S.; Zondervan, K.T.; et al. Endometriosis and cancer: A systematic review and meta-analysis. Hum. Reprod. Update 2021, 27, 393–420. [Google Scholar] [CrossRef] [PubMed]
- Saavalainen, L.; Lassus, H.; But, A.; Tiitinen, A.; Härkki, P.; Gissler, M.; Pukkala, E.; Heikinheimo, O. Risk of gynecologic cancer according to the type of endometriosis. Obstet. Gynecol. 2018, 131, 1095–1102. [Google Scholar] [CrossRef]
- Tanha, K.; Mottaghi, A.; Nojomi, M.; Moradi, M.; Rajabzadeh, R.; Lotfi, S.; Janani, L. Investigation on factors associated with ovarian cancer: An umbrella review of systematic review and meta-analyses. J. Ovarian Res. 2021, 14, 153. [Google Scholar] [CrossRef]
- Mortlock, S.; Corona, R.I.; Kho, P.F.; Pharoah, P.; Seo, J.H.; Freedman, M.L.; Gayther, S.A.; Siedhoff, M.T.; Rogers, P.A.; Leuchter, R.; et al. A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes. Cell. Rep. Med. 2022, 3, 100542. [Google Scholar] [CrossRef]
- Becker, C.M.; Bokor, A.; Heikinheimo, O.; Horne, A.; Jansen, F.; Kiesel, L.; King, K.; Kvaskoff, M.; Nap, A.; Petersen, K.; et al. ESHRE guideline: Endometriosis. Hum. Reprod. Open. 2022, 2022, hoac009. [Google Scholar] [CrossRef] [PubMed]
- National Cancer Institute. SEER Cancer Statistics Review (CSR) 2017–2019. Available online: https://seer.cancer.gov/statfacts/html/ovary.html (accessed on 29 July 2022).
- Matalliotakis, I.; Mahutte, N.G.; Koukoura, O.; Arici, A. Endometriosis associated with Stage IA clear cell ovarian carcinoma in a woman with IVF-ET treatments in the Yale Series. Arch. Gynecol. Obstet. 2006, 274, 184–186. [Google Scholar] [CrossRef] [PubMed]
- Saylam, K.; Devreker, F.; Simon, P.; Fayt, I.; Noël, J.C. Ovarian clear cell carcinoma occurring in a young patient with endometriosis and long-term ovulation stimulations. Acta Obstet. Gynecol. Scand. 2006, 85, 1506–1507. [Google Scholar] [CrossRef] [PubMed]
- Tagashira, Y.; Shimada, M.; Kigawa, J.; Iba, T.; Terakawa, N. Ovarian endometrioid adenocarcinoma arising from endometriosis in a young woman. Gynecol. Oncol. 2003, 91, 643–647. [Google Scholar] [CrossRef]
- Woodard, T.L.; Awonuga, A.O.; Puscheck, E. Malignant Transformation of Endometrioma in a Woman with a History of Ovulation Induction and In Vitro Fertilization. Case Rep. Med. 2012, 2012, 497362. [Google Scholar] [CrossRef]
- Wang, S.; Qiu, L.; Lang, J.H.; Shen, K.; Yang, J.X.; Huang, H.F.; Pan, L.Y.; Wu, M. Clinical analysis of ovarian epithelial carcinoma with coexisting pelvic endometriosis. Am. J. Obstet. Gynecol. 2013, 208, 413.e1–413.e5. [Google Scholar] [CrossRef]
- Cai, Y.; Yin, J.; Jin, Y.; Li, Y.; Wu, M.; Yang, J.; Huang, H.; Leng, J.; Pan, L. Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: A 12-year cohort study. Eur. J. Surg. Oncol. 2020, 46, 876–882. [Google Scholar] [CrossRef] [PubMed]
- Li, Q.; Sun, Y.; Zhang, X.; Wang, L.; Wu, W.; Wu, M.; Meng, C.; Liu, G. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics. Cancer Biol. Ther. 2019, 20, 1029–1034. [Google Scholar] [CrossRef]
- Moro, F.; Magoga, G.; Pasciuto, T.; Mascilini, F.; Moruzzi, M.C.; Fischerova, D.; Savelli, L.; Giunchi, S.; Mancari, R.; Franchi, D.; et al. Imaging in gynecological disease (13): Clinical and ultrasound characteristics of endometrioid ovarian cancer. Ultrasound Obstet. Gynecol. 2018, 52, 535–543. [Google Scholar] [CrossRef]
- Pozzati, F.; Moro, F.; Pasciuto, T.; Gallo, C.; Ciccarone, F.; Franchi, D.; Mancari, R.; Giunchi, S.; Timmerman, D.; Landolfo, C.; et al. Imaging in gynecological disease (14): Clinical and ultrasound characteristics of ovarian clear cell carcinoma. Ultrasound Obstet. Gynecol. 2018, 52, 792–800. [Google Scholar] [CrossRef]
- Younis, J.S.; Izhaki, I. At what age endometriosis-associated ovarian cancer is diagnosed? The implications for women in the reproductive age. Front. Oncol. 2023, 13, 1193123. [Google Scholar] [CrossRef]
- Udomsinkul, P.; Triratanachart, S.; Oranratanaphan, S. Risk factors for endometriotic-cyst associated ovarian cancer: A case controlled study. Taiwan. J. Obstet. Gynecol. 2020, 59, 269–274. [Google Scholar] [CrossRef] [PubMed]
- Hernández, A.; Sanz, A.; Spagnolo, E.; Carbonell, M.; Rodríguez, E.; López, A.; Raganato, R.; Del Forno, S.; Ramiro-Cortijo, D. Evaluation of Women’s Age and Ultrasonographic Features to Choose Surgical Treatment for Endometriosis Associated with Ovarian Cancer. J. Clin. Med. 2022, 11, 2414. [Google Scholar] [CrossRef] [PubMed]
- Huang, K.J.; Li, Y.X.; Wu, C.J.; Chang, W.C.; Wei, L.H.; Sheu, B.C. Sonographic features differentiating early-stage ovarian clear cell carcinoma from endometrioma with atypical features. J. Ovarian Res. 2022, 15, 84. [Google Scholar] [CrossRef]
- Thomsen, L.H.; Schnack, T.H.; Buchardi, K.; Hummelshoj, L.; Missmer, S.A.; Forman, A.; Blaakaer, J. Risk factors of epithelial ovarian carcinomas among women with endometriosis: A systematic review. Acta Obstet. Gynecol. Scand. 2017, 96, 761–778. [Google Scholar] [CrossRef]
- Giannini, A.; Bogani, G.; Vizza, E.; Chiantera, V.; Laganà, A.S.; Muzii, L.; Salerno, M.G.; Caserta, D.; D’Oria, O. Advances on Prevention and Screening of Gynecologic Tumors: Are We Stepping Forward? Healthcare 2022, 10, 1605. [Google Scholar] [CrossRef] [PubMed]
- Sisodia, R.C.; Del Carmen, M.G. Lesions of the Ovary and Fallopian Tube. N. Engl. J. Med. 2022, 287, 727–736. [Google Scholar] [CrossRef]
- Nisenblat, V.; Bossuyt, P.M.; Shaikh, R.; Farquhar, C.; Jordan, V.; Scheffers, C.S.; Mol, B.W.; Johnson, N.; Hull, M.L. Blood biomarkers for the 700 non-invasive diagnosis of endometriosis. Cochrane Database Syst. Rev. 2016, 2016, CD012179. [Google Scholar]
- Younis, J.S. Endometriosis-associated ovarian cancer: What are the implications for women with intact endometrioma planning for a future pregnancy? A reproductive clinical outlook. Biomolecules 2022, 12, 1721. [Google Scholar] [CrossRef]
- Barreta, A.; Sarian, L.; Ferracini, A.C.; Eloy, L.; Brito, A.B.C.; de Angelo Andrade, L.; Derchain, S. Endometriosis-Associated Ovarian Cancer: Population Characteristics and Prognosis. Int. J. Gynecol. Cancer 2018, 28, 1251–1257. [Google Scholar] [CrossRef]
- Guerriero, S.; Van Calster, B.; Somigliana, E.; Ajossa, S.; Froyman, W.; De Cock, B.; Coosemans, A.; Fischerová, D.; Van Holsbeke, C.; Alcazar, J.L.; et al. Age-related differences in the sonographic characteristics of endometriomas. Hum. Reprod. 2016, 31, 1723–1731. [Google Scholar] [CrossRef]
- Robinson, K.A.; Menias, C.O.; Chen, L.; Schiappacasse, G.; Shaaban, A.M.; Caserta, M.P.; Elsayes, K.M.; Van Buren, W.M.; Bolan, C.W. Understanding malignant transformation of endometriosis: Imaging features with pathologic correlation. Abdom. Imaging 2019, 45, 1762–1775. [Google Scholar] [CrossRef] [PubMed]
- Tanaka, Y.O.; Yoshizako, T.; Nishida, M.; Yamaguchi, M.; Sugimura, K.; Itai, Y. Ovarian carcinoma in patients with endometriosis: MR imaging findings. Am. J. Roentgenol. 2000, 175, 1423–1430. [Google Scholar] [CrossRef] [PubMed]
- Tanase, Y.; Kawaguchi, R.; Takahama, J.; Kobayashi, H. Factors that differentiate between endometriosis-associated ovarian cancer and benign ovarian endometriosis with mural nodules. Magn. Reson. Med. Sci. 2018, 17, 231–237. [Google Scholar] [CrossRef] [PubMed]
- Zhang, X.; Li, M.; Tang, Z.; Li, X.; Song, T. Differentiation between endometriosis-associated ovarian cancers and non-endometriosis-associated ovarian cancers based on magnetic resonance imaging. Br. J. Radiol. 2021, 94, 20201441. [Google Scholar] [CrossRef]
- Younis, J.S.; Nelson, S.M. What is the recommended management of a young woman with an intact endometrioma desiring future fertility? Front. Endocrinol. 2022, 13, 1005597. [Google Scholar] [CrossRef]
- Raffi, F.; Metwally, M.; Amer, S. The impact of excision of ovarian endometrioma on ovarian reserve: A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2012, 97, 3146–3154. [Google Scholar] [CrossRef] [PubMed]
- Younis, J.S.; Shapso, N.; Fleming, R.; Ben-Shlomo, I.; Izhaki, I. Impact of unilateral versus bilateral ovarian endometriotic cystectomy on ovarian reserve: A systematic review and meta-analysis. Hum. Reprod. Update 2019, 25, 375–391. [Google Scholar] [CrossRef]
- Younis, J.S.; Shapso, N.; Ben-Sira, Y.; Nelson, S.M.; Izhaki, I. Endometrioma surgery-a systematic review and meta-analysis of the effect on antral follicle count and anti-Müllerian hormone. Am. J. Obstet. Gynecol. 2022, 226, 33–51.e7. [Google Scholar] [CrossRef]
- Vercellini, P.; Somigliana, E.; Viganò, P.; Abbiati, A.; Barbara, G.; Crosignani, P.G. Surgery for endometriosis-associated infertility: A pragmatic approach. Hum. Reprod. 2009, 24, 254–269. [Google Scholar] [CrossRef]
- Leonardi, M.; Gibbons, T.; Armour, M.; Wang, R.; Glanville, E.; Hodgson, R.; Cave, A.E.; Ong, J.; Tong, Y.Y.F.; Jacobson, T.Z.; et al. When to Do Surgery and When Not to Do Surgery for Endometriosis: A Systematic Review and Meta-analysis. J. Minim. Invasive Gynecol. 2020, 27, 390–407.e3. [Google Scholar] [CrossRef]
- Hamdan, M.; Dunselman, G.; Li, T.C.; Cheong, Y. The impact of endometrioma on IVF/ICSI outcomes: A systematic review and meta-analysis. Hum. Reprod. Update 2015, 21, 809–825. [Google Scholar] [CrossRef] [PubMed]
- Laursen, J.B.; Schroll, J.B.; Macklon, K.T.; Rudnicki, M. Surgery versus conservative management of endometriomas in subfertile women. A systematic review. Acta Obstet. Gynecol. Scand. 2017, 96, 727–735. [Google Scholar] [CrossRef]
- Alshehre, S.M.; Narice, B.F.; Fenwick, M.A.; Metwally, M. The impact of endometrioma on in vitro fertilisation/intra-cytoplasmic injection IVF/ICSI reproductive outcomes: A systematic review and meta-analysis. Arch. Gynecol. Obstet. 2021, 303, 3–16. [Google Scholar] [CrossRef] [PubMed]
- Somigliana, E.; Benaglia, L.; Paffoni, A.; Busnelli, A.; Vigano, P.; Vercellini, P. Risks of conservative management in women with ovarian endometriomas undergoing IVF. Hum. Reprod. Update 2015, 21, 486–499. [Google Scholar] [CrossRef] [PubMed]
- Benaglia, L.; Busnelli, A.; Biancardi, R.; Vegetti, W.; Reschini, M.; Vercellini, P.; Somigliana, E. Oocyte retrieval difficulties in women with ovarian endometriomas. Reprod. Biomed. Online 2018, 37, 77–84. [Google Scholar] [CrossRef] [PubMed]
- Younis, J.S. Is oocyte quality impaired in cases with ovarian endometriosis? A second look into the clinical setting. Front. Endocrinol. 2022, 13, 921032. [Google Scholar] [CrossRef] [PubMed]
- Kennedy, S.; Bergqvist, A.; Chapron, C.; D’Hooghe, T.; Dunselman, G.; Greb, R.; Hummelshoj, L.; Prentice, A.; Saridogan, E. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum. Reprod. 2005, 20, 2698–2704. [Google Scholar] [CrossRef]
- Chao, X.; Wang, S.; Lang, J.; Leng, J.; Fan, Q. The application of risk models based on machine learning to predict endometriosis-associated ovarian cancer in patients with endometriosis. Acta Obstet. Gynecol. Scand. 2022, 101, 1440–1449. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Younis, J.S. Should Endometriosis-Associated Ovarian Cancer Alter the Management of Women with an Intact Endometrioma in the Reproductive Age? Reprod. Med. 2023, 4, 100-105. https://doi.org/10.3390/reprodmed4020011
Younis JS. Should Endometriosis-Associated Ovarian Cancer Alter the Management of Women with an Intact Endometrioma in the Reproductive Age? Reproductive Medicine. 2023; 4(2):100-105. https://doi.org/10.3390/reprodmed4020011
Chicago/Turabian StyleYounis, Johnny S. 2023. "Should Endometriosis-Associated Ovarian Cancer Alter the Management of Women with an Intact Endometrioma in the Reproductive Age?" Reproductive Medicine 4, no. 2: 100-105. https://doi.org/10.3390/reprodmed4020011